Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2017
The purpose of this study is to determine if PF-06687234 is effective and safe as add-on therapy to infliximab in subjects with active ulcerative colitis who are not in remission.
Epistemonikos ID: 343580b57e57b55785faca6fbfe11a8f1b8ace33
First added on: Mar 23, 2022